Inventor · disambiguated record
David Ching Siang Huang
Also filed as: HUANG DAVID · HUANG DAVID C S · HUANG DAVID CHING S · HUANG DAVID CHING SIANG
9 granted patents·15 pending applications·135 citations·filing 1996–2023
87Inventor score
Files withINST MEDICAL W & E HALL5MOTIF BIOSCIENCES INC4ABBVIE INC2LAHOUD MIREILLE HANNA2ABBOTT LAB1
Top patents by PatentIndex Score
24 records- 0189US7064193B1Therapeutic moleculesINST MEDICAL W & E HALL·Filed 1998·Granted Jun 20, 2006·100 cites·7 claims
- 0288US7582439B2Therapeutic moleculesINST MEDICAL W & E HALL·Filed 2006·Granted Sep 1, 2009·13 cites·18 claims
- 0379US10076522B2Systems and methods for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Granted Sep 18, 2018·5 cites·29 claims
- 0468US8686110B2Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the sameCOLMAN PETER MALCOLM·Filed 2006·Granted Apr 1, 2014·2 cites·13 claims
- 0568US8399484B2Combination therapy for treating HCV infectionHUANG DAVID·Filed 2009·Granted Mar 19, 2013·2 cites·28 claims
- 0666US2010087436A1Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejectionABBOTT LAB·Filed 2009·Application pending·0 cites
- 0763US7572900B2Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosisINST MEDICAL W & E HALL·Filed 2002·Granted Aug 11, 2009·4 cites·6 claims
- 0862US2020038399A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0960US10080751B2Systems and methods for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 1060US2024115654A1Intravenous administration of engineered antimicrobial amphiphilic peptidesPEPTILOGICS INC·Filed 2023·Application pending·0 cites
- 1155US2018133218A1Formulations, methods, kit, and dosage forms for treating bacterial infectionMOTIF BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 1253US2010199368A1Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosisINST MEDICAL W & E HALL·Filed 2009·Application pending·0 cites
- 1352US2024317809A1Engineered Antimicrobial Peptides and Usage ThereofUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1450US2007054846A1Bcl-w structure and uses thereforHINDS MARK G·Filed 2003·Application pending·0 cites
- 1549US2011110861A1Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead CellsLAHOUD MIREILLE HANNA·Filed 2009·Application pending·0 cites
- 1648US2016175316A1Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejectionABBVIE INC·Filed 2015·Application pending·0 cites
- 1746US2014335104A1Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead CellsINST MEDICAL W & E HALL·Filed 2014·Application pending·0 cites
- 1846US2015265721A1Compounds and Methods for Modulating an Immune ResponseBURNET INST·Filed 2014·Application pending·0 cites
- 1945US2010197711A1Benzothiazole compoundsWATSON KEITH GEOFFREY·Filed 2007·Application pending·0 cites
- 2045US2015211075A1Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancersABBVIE INC·Filed 2015·Application pending·0 cites
- 2142US9045800B2Methods and compositions for identifying, classifying and monitoring subject having Bcl-2 family inhibitor-resistant tumors and cancersSEMIZAROV DIMITRI·Filed 2010·Granted Jun 2, 2015·0 cites·22 claims
- 2240US6294340B1Method of binding material to the β-amyloid peptideUNIV DUKE·Filed 1996·Granted Sep 25, 2001·9 cites·12 claims
- 2334US2008027145A1Therapeutic Molecules and Methods for Generating and/or Selecting SameHUANG DAVID C S·Filed 2005·Application pending·0 cites
- 2433US2012039806A1Compounds and Methods for Modulating an Immune ResponseLAHOUD MIREILLE HANNA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →